| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |